Education
About Us
Working with TipRanks
Follow Us
Coeptis Therapeutics Holdings (COEP)
NASDAQ:COEP
Total Valuation
Coeptis Therapeutics Holdings has a market cap or net worth of $78.29M. The enterprise value is ―.
Market Cap$78.29M
Enterprise Value―
Share Statistics
Coeptis Therapeutics Holdings has 5,340,111 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,340,111
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Coeptis Therapeutics Holdings’s return on equity (ROE) is -3.08 and return on invested capital (ROIC) is -161.24%.
Return on Equity (ROE)-3.08
Return on Assets (ROA)-1.10
Return on Invested Capital (ROIC)-161.24%
Return on Capital Employed (ROCE)-2.29
Revenue Per Employee0.00
Profits Per Employee-2.18M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Coeptis Therapeutics Holdings is ―. Coeptis Therapeutics Holdings’s PEG ratio is -0.00186.
PE Ratio―
PS Ratio0.00
PB Ratio3.32
Price to Fair Value3.32
Price to FCF-1.59
Price to Operating Cash Flow-10.02
PEG Ratio-0.00186
Income Statement
In the last 12 months, Coeptis Therapeutics Holdings had revenue of 0.00 and earned -10.88M in profits. Earnings per share was -5.65.
Revenue0.00
Gross Profit-1.04M
Operating Income-10.05M
Pretax Income-10.88M
Net Income-10.88M
EBITDA-9.44M
Earnings Per Share (EPS)-5.65
Cash Flow
In the last 12 months, operating cash flow was -8.35M and capital expenditures -3.00, giving a free cash flow of -8.35M billion.
Operating Cash Flow-8.35M
Free Cash Flow-8.35M
Free Cash Flow per Share-1.56
Dividends & Yields
Coeptis Therapeutics Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.33
52-Week Price Change425.45%
50-Day Moving Average15.49
200-Day Moving Average12.01
Relative Strength Index (RSI)43.40
Average Volume (3m)40.59K
Important Dates
Coeptis Therapeutics Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Coeptis Therapeutics Holdings as a current ratio of 0.23, with Debt / Equity ratio of 0.96%
Current Ratio0.23
Quick Ratio0.23
Debt to Market Cap0.13
Net Debt to EBITDA-0.09
Interest Coverage Ratio-25.38
Taxes
In the past 12 months, Coeptis Therapeutics Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.10
Enterprise Valuation
Coeptis Therapeutics Holdings EV to EBITDA ratio is -1.21, with an EV/FCF ratio of -1.72.
EV to Sales0.00
EV to EBITDA-1.21
EV to Free Cash Flow-1.72
EV to Operating Cash Flow-1.72
Balance Sheet
Coeptis Therapeutics Holdings has $5.33M in cash and marketable securities with $279.87K in debt, giving a net cash position of $5.05M billion.
Cash & Marketable Securities$5.33M
Total Debt$279.87K
Net Cash$5.05M
Net Cash Per Share$0.95
Tangible Book Value Per Share$1.73
Margins
Gross margin is 54.86%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin54.86%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Coeptis Therapeutics Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―